Actively Recruiting
The Impact of Cognitive Behavioral Therapy for Insomnia (CBT-I) on Glycemic Control in Older Type 2 Diabetes (T2D) Comorbid With Insomnia
Led by Chinese University of Hong Kong · Updated on 2025-07-11
214
Participants Needed
1
Research Sites
226 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a RCT aiming to use CBT-I as intervention, compared to usual care as control, to elucidate the effect of CBT-I on glycemic control, sleep quality, psychological outcomes, and cognitive function in Hong Kong Chinese older T2D comorbid with insomnia.
CONDITIONS
Official Title
The Impact of Cognitive Behavioral Therapy for Insomnia (CBT-I) on Glycemic Control in Older Type 2 Diabetes (T2D) Comorbid With Insomnia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 60 years or older
- Diagnosed with type 2 diabetes with HbA1c between 7.1% and 10%
- Of Chinese ethnicity
- Have insomnia with an Insomnia Severity Index (ISI) score greater than 10
- Able and willing to give informed written consent
You will not qualify if you...
- Cognitive impairment with HK-MoCA score of 22 or less
- Depression with GDS-15 score greater than 8 or other psychiatric disorders such as generalized anxiety disorder, restless leg syndrome, or schizophrenia
- History of benign prostatic hypertrophy or elevated PSA, or other chronic medical conditions affecting sleep such as chronic pain
- Current use of hypnotic drugs, psychotic medications, or any drugs known to affect sleep
- History of cerebrovascular accidents, vascular dementia, or other conditions affecting cognitive function
- Shift workers
- Conditions affecting the validity of HbA1c measurement such as haemoglobinopathies, renal failure, or need for regular blood transfusion
- Any condition deemed by investigators as ineligible for participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Medicine and Therapeutics, The Chinese University of Hong Kong (CUHK), Ward 3M, Diabetes and Endocrine Research Centre, 3/F Day Treatment Block and Children Wards (Old Block), Prince of Wales Hospital
Hong Kong, Hong Kong
Actively Recruiting
Research Team
A
Alice Kong, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here